The goal of this study is to assess the effect of fennel on bone density. Methods: This was a double-blind, randomized, placebo-controlled trial, which studied sixty eligible postmenopausal women, who were randomly assigned to fennel and placebo groups. Then, the dual energy X-ray absorptiometry was utilized to measure bone mineral density (BMD) and bone mineral content (BMC) of the spine, femoral neck, intertrochanter, and trochanter at the baseline and after three-month follow-up. Results: The mean BMD and BMC at lumbar spine (P = 0.14, P = 0.504), total hip femoral (P = 0.427, P = 0.471), trochanter (P = 0.075, P = 0.07), intertrochanter, (P = 0.864, P = 0.932) and femoral neck (P = 0.439, P = 0.641) was not significantly different between the fennel and placebo groups.
Introduction
Osteoporosis is a leading cause of disability and death among elderly women which imposes huge economic costs on the society. 1, 2 Estrogens are integral to skeletal homeostasis, with ovarian hormone deficiency acting as critical risk factors of osteoporosis. There are strong evidences on bonerelated benefits of raloxifene and hormone replacement therapy (HRT). 3, 4 However, short-term estrogen use can lead to vaginal bleeding, while long-term use can increase the risk of breast cancer, stroke and cardiovascular disease. 5 The main side effects of raloxifene are vein thromboses and pulmonary embolism. As a result, many postmenopausal women favor compounds that contain non-hormonal materials like phytoestrogens as a safer option. 6~9 Phytoestrogens are plant substances with a structure and function similar to estradiol, which is responsible for estrogenic effect. 10 Phytoestrogens have been the subject of growing attention for 
Materials and Methods
This is part of a study that assessed the effect of fennel Then, dual-energy X-ray absorptiometry (DXA; Hologic QDR-2000 Inc., Bedford, MA, USA) was utilized to measure BMD and BMC of the spine, femoral neck, intertrochanteric, and trochanter at the baseline and after three months. 16 The subject screening was performed every 4 weeks to check for any side effect and compliance. To ensure compliance, patients were asked to bring their medication bottle to each visit to count the pills.
Statistical tests
The normal distribution of data was examined using the Kolmogorov-Smirnov test of normality. Paired t-tests (intra group) was used to draw a comparison between the baseline and three-month follow-up, and Student' s t-test (inter groups) was used to compare the two treatment groups, Statistical tests were two-sided, and a P values of less than 0.05 were considered to indicate statistical significance.
Results
The two groups were similar in variables such as age, history of hysterectomy, body weight, body mass index (BMI) J MM and duration of menopause at the baseline, as shown in Table 1 . Side effects were observed in 6 subjects in the fennel group and 3 subjects in the placebo group. In the fennel group, subjects complained of allergic rash (n = 1), weight gain (n = 1), hypertension (n = 1) and vaginal bleeding (n = 2). Only one patient in placebo group complained of stomachache. The fennel was different from placebo in term of the mean BMD and BMC at lumbar spine (P = 0.14, P = 0.504), total hip femoral (P = 0.427, P = 0.471), trochanter (P = 0.075, P = 0.07), intertrochanter (P = 0.864, P = 0.932) and femoral neck (P = 0.439, P = 0.641) ( Table 2 ). Also, no significant difference was observed in both groups at the baseline and three-month follow-up in terms of mean BMD and BMC at lumbar spine, total hip femoral, trochanter and intertrochanter (the data is not shown in the Table) Discussion
To the best of our knowledge, this is the first study to as- Despite our efforts, no human study about the effects of Foeniculum vulgare on bone density was found. Nevertheless, considering that phytoestrogen is an active biological compound in fennel, we referred to studies that evaluated the effect of phytoestrogen on BMC and BMD. Phytoestrogens are plant compounds with properties that resemble those of estrogen. There are four main groups of phytoestrogens: isoflavones, lignans, flavonoids and coumestans. 10 Isoflavones are found in soy and red clover extracts; soy isoflavones are mainly composed of genistein and daidzein, but red clover isoflavones consist of formononetin and biochanin. 2 Lignans are commonly found in flaxseed 11 and
Foeniculum vulgare is considered as a major source of flavonoids. 13 Although the positive effect of soy isoflavone has been demonstrated in a number of studies 17, 18 other studies have not reported any beneficial effect (Table 3 ). 18~21 We found three studies assessing the effect of red clover on bone density. The first study was by Atkinson according to which red clover isoflavones enriched with biochanin had a beneficial effect on spine BMD and BMC, but not on hip BMD and BMC over a 24-month follow-up. 3 In the second study by Clifton-Bligh, no significant difference was observed in BMD loss in the spine, hip and forearm after 24 months of treatment with red clover isoflavones enriched with formononetin. 22 The third trial by Thorup showed that 150 mL/day red clover could improve bone status.
23
A systematic review of five trials by Abdi revealed an increase in BMD and bone turnover after genistein administration in postmenopausal women. They also found that it was impossible to make conclusive statements about the effect of soy on BMD in postmenopausal women due to heterogeneity in formulation, phytoestrogen content, and dosage of supplement. 24 The results of an in vitro study showed that Foeniculum vulgare extract in the range of 5 to 50 μ g/mL might have The data is presented as mean ± standard deviation or number (%) 15 This is inconsistent with the findings of this study.
Limitations of the study
In this study, postmenopausal women were followed only for 12 weeks. Further studies can focus on longer durations and larger sample sizes to explore their beneficial effects.
Conclusion
Foeniculum vulgare did not have any significant effect on BMC and BMD at lumbar spine and total hip in post-menopausal women. Further studies with longer durations and larger sample sizes are recommended to validate the results of this study. Brink et al. 21 1 year Isoflavone-enriched products placebo Isoflavone-enriched products had no effect on BMD at the lumbar spine.
Arjmandi et al. 27 1 year Consumption of soy-containing foods (providing 25 g protein and 60 mg isoflavones)
No significant changes in total hip BMD and BMC.
Ye et al. 20 6 months 84 and 126 mg isoflavones Mean percent changes increased in soy isoflavones group regarding BMD at the lumbar spine (P = 0.114) and femoral neck (P = 0.053).
Chi and Zhang 17 6 months isoflavone (90 mg/day) and with placebo Both tibia bone density and limb bone density increased compared to at baseline. However it reach significant level only in tibia bone density.
Huang et al. 18 1 year 100 mg/day isoflavone (IF100) and 200 mg/day isoflavone (IF200) groups Soy isoflavone showed significant positive effect on spin BMD.
BMD: bone mineral density, BMC: bone mineral content
